logo
logo

Orthogon Therapeutics Announces An $8M Follow-On Financing To Advance Its Lead Bk Virus Drug

Nov 08, 2021•over 3 years ago

Amount Raised

$8 Million

Canton

Description

Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has raised an $8M round from a leading syndicate of US based healthcare Angels to advance its pipeline of first-in-class drug assets. This financing brings the total investment to date in the Company to $12.5M.

Company Information

Company

Orthogon Therapeutics

Location

Canton, Texas, United States

About

Orthogon Therapeutics is a privately held R&D company. Orthogon uses structure-based drug design and biophysics to successfully optimize drugs that bind selectively and safely neutralize target proteins that have been considered difficult to “drug”. The Company was founded by a veteran biotech entrepreneur and experienced drug discovery scientists with a mission to prolong and improve patient quality of life.